VRAY has been on a downtrend this whole year however there has been significant buying activity lately. The weekly MACD is about to turn bullish while the RSI has just had a higher low and is trying to come out of oversold territory.
Currently VRAY is close to its 52 week low price. There has been large buying activity from the insiders, CEO, CSO (chief...
ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical...
VRAY has been forming a descending triangle since March 31st, and with good news coming in it looks like it might break through soon. Both the Stoch and RSI are neutral and the ADX is signalling a possible reversal.
VRAY is reaching a long term resistance. A strong rejection on that level could be a good short setup. Potential harmonic pattern on 4h chart. A strong breakout above the downward trendline invalidates this setup.
ViewRay, Inc. engages in the design, manufacture and market magnetic resonance imaging (MRI) system. It develops MRIdian to address the key limitations of existing external-beam radiation therapy technologies, and employs MRI-based technology to provide real-time imaging that clearly defines the targeted tumor from the surrounding soft tissue, and other critical organs, both before and during radiation treatment delivery. The company was founded by Dinara Akzhigitova on September 6, 2013 and is headquartered in Oakwood Village, OH.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
VRAY
